Timotius Ivan Hariyanto
Overview
Explore the profile of Timotius Ivan Hariyanto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zufry H, Hariyanto T
J Am Soc Cytopathol
. 2025 Jan;
PMID: 39843308
Introduction: The rate of nondiagnostic and indeterminate cytology findings from fine-needle aspiration biopsy (FNAB) is quite high, resulting in repeated puncture and unnecessary surgery. The primary objective of this investigation...
2.
Japar K, Hariyanto T, Hamzah D, Prasetya I, Suastika K
Probiotics Antimicrob Proteins
. 2025 Jan;
PMID: 39806201
The absence of suitable intervention significantly increases the likelihood of type 2 diabetes mellitus (T2DM) development in people with prediabetes. Recent statistical findings indicate that the gut microbiome might influences...
3.
Suharyani S, Leonardo M, Oentoeng H, Pardamean Lumban Tobing E, Tansol C, Hariyanto T
Asian J Urol
. 2024 Nov;
11(4):545-554.
PMID: 39534000
Objective: Intracavernous injection might be offered to patients with erectile dysfunction (ED) who did not respond to the first-line oral treatment. Platelet-rich plasma (PRP) might offer improvement in erectile function...
4.
Mulyani Soetedjo N, Permana H, Hariyanto T, Tendean M, Kusumawati M, Ritonga E, et al.
Diabetes Res Clin Pract
. 2024 Oct;
205:110984.
PMID: 39445433
Aims: The primary objective of this investigation is to examine the efficacy and safety of insulin icodec when compared to regular basal insulin for the management of type 2 diabetes...
5.
Silalahi T, Hariyanto T
Ther Adv Neurol Disord
. 2024 Oct;
17:17562864241271033.
PMID: 39371639
Background: Although often asymptomatic, patent foramen ovale (PFO) may cause disabling migraine symptoms. Evidence regarding PFO closure for prevention of migraine is still ambiguous and conflicting. Objectives: This study aims...
6.
Zufry H, Zulfa P, Hariyanto T
Biosci Microbiota Food Health
. 2024 Oct;
43(4):300-308.
PMID: 39364132
Emerging research indicates the potential involvement of gut bacteria in the etiology of Graves' Disease (GD). However, the evidence regarding this matter is still conflicting. The primary objective of this...
7.
Vatvani A, Patel P, Hariyanto T, Yanto T
Korean J Pain
. 2024 Sep;
37(4):367-378.
PMID: 39344363
Background: Fibromyalgia is characterized by the presence of chronic widespread pain that may impair patient's quality of life. Currently, the use of naltrexone as a therapeutic agent for fibromyalgia is...
8.
Zufry H, Hariyanto T
Endocrinol Metab (Seoul)
. 2024 Aug;
39(4):603-614.
PMID: 39086275
Backgruound: Both Graves' disease (GD) and Hashimoto's thyroiditis (HT) are classified as autoimmune thyroid diseases (AITDs). It has been hypothesized that changes in the thyroid-stimulating hormone receptor (TSHR) gene may...
9.
Yanto T, Vatvani A, Hariyanto T, Suastika K
Diabetes Metab Syndr
. 2024 Jul;
18(6):103069.
PMID: 38963997
Background: Glucagon-like peptide-1 receptor agonist (GLP-1RA) is incretin-based therapy that possessed significant glucose lowering and weight loss properties. The present study aims to analyze the efficacy of GLP-1RA in the...
10.
Zufry H, Hariyanto T
Korean J Radiol
. 2024 Feb;
25(3):301-313.
PMID: 38413114
Objective: The current body of evidence lacks clarity regarding the comparative efficacy and safety of radiofrequency ablation (RFA) and microwave ablation (MWA) as minimally invasive treatments for benign thyroid nodules....